Neurovalens
Northern Ireland, GB · 10 known investors
Neurovalens develops medical devices using neuromodulation technology to address health conditions including obesity and anxiety disorders. The company conducts research and development activities supported by European funding programs.
Founders & leadership
DJ
Dr. Jason McKeownMD PhD, Founder
Investors · 10
Clarendon Fund Managers Ltd.Belfast · $25K – $3.9M
.jpeg){kind=logo}
IQ CapitalLondon · $1M – $40M
Beltrae Partnersreported · 2 sourcesBelfast · $1M – $15M
British Business Bankreported · 2 sourcesSheffield
Invest Northern Irelandreported · 2 sourcesBelfast
Techstart Venturesreported · 2 sourcesEdinburgh · $950K
Also in the syndicate · 4
Angel Co FundClarendon Fund ManagementMedTech InnovatorWharton Asset Management
Funding
SEC filings, press & company announcements- Undisclosed amountfunding roundApr 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Neurovalens do?
- Neurovalens develops medical devices using neuromodulation technology to address health conditions including obesity and anxiety disorders. The company conducts research and development activities supported by European funding programs.
- Who founded Neurovalens?
- Neurovalens was founded by Dr. Jason McKeown.
- Who are Neurovalens's investors?
- Neurovalens's investors include Clarendon Fund Managers Ltd., IQ Capital, Beltrae Partners, British Business Bank, Invest Northern Ireland, Techstart Ventures.
- Where is Neurovalens headquartered?
- Neurovalens is headquartered in Northern Ireland, GB.